Fig. 1.
Percentage of chelation-naïve (n = 123) and prechelated patients with myelodysplastic syndromes (n = 44) who attended follow-up visits.
Percentage of chelation-naïve (n = 123) and prechelated patients with myelodysplastic syndromes (n = 44) who attended follow-up visits.